Neuron
Volume 83, Issue 5, 3 September 2014, Pages 1043-1050
Journal home page for Neuron

Report
Discovery of a Biomarker and Lead Small Molecules to Target r(GGGGCC)-Associated Defects in c9FTD/ALS

https://doi.org/10.1016/j.neuron.2014.07.041Get rights and content
Under an Elsevier user license
open archive

Highlights

  • (GGGGCC) RNA forms a hairpin structure in equilibrium with a G-quadruplex structure

  • Neurons directly converted from C9ORF72+ fibroblasts express c9RAN proteins and foci

  • Small-molecule binders of (GGGGCC)exp RNA ameliorate c9FTD/ALS-associated defects

  • c9RAN proteins are detected in c9ALS patient cerebrospinal fluid

Summary

A repeat expansion in C9ORF72 causes frontotemporal dementia and amyotrophic lateral sclerosis (c9FTD/ALS). RNA of the expanded repeat (r(GGGGCC)exp) forms nuclear foci or undergoes repeat-associated non-ATG (RAN) translation, producing “c9RAN proteins.” Since neutralizing r(GGGGCC)exp could inhibit these potentially toxic events, we sought to identify small-molecule binders of r(GGGGCC)exp. Chemical and enzymatic probing of r(GGGGCC)8 indicate that it adopts a hairpin structure in equilibrium with a quadruplex structure. Using this model, bioactive small molecules targeting r(GGGGCC)exp were designed and found to significantly inhibit RAN translation and foci formation in cultured cells expressing r(GGGGCC)66 and neurons transdifferentiated from fibroblasts of repeat expansion carriers. Finally, we show that poly(GP) c9RAN proteins are specifically detected in c9ALS patient cerebrospinal fluid. Our findings highlight r(GGGGCC)exp-binding small molecules as a possible c9FTD/ALS therapeutic and suggest that c9RAN proteins could potentially serve as a pharmacodynamic biomarker to assess efficacy of therapies that target r(GGGGCC)exp.

Cited by (0)

13

Co-first author